Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 7 de 7
Filtrar
1.
J Infect Chemother ; 26(5): 418-428, 2020 May.
Artículo en Inglés | MEDLINE | ID: mdl-32081647

RESUMEN

The antimicrobial susceptibility patterns of bacterial pathogens isolated from patients with complicated urinary tract infections were analyzed using national surveillance data. The data consisted of 881 bacterial strains from eight clinically relevant species. The data were collected for the third national surveillance project from January 2015 to March 2016 by the Japanese Society of Chemotherapy, the Japanese Association for Infectious Disease, and the Japanese Society of Clinical Microbiology. Surveillance was undertaken with the cooperation of 41 medical institutions throughout Japan. Fluoroquinolone required a MIC90 of 2-64 mg/L to inhibit the 325 Escherichia coli strains tested and the proportion of levofloxacin resistant E. coli strains increased to 38.5% from 29.6% in 2011 and 28.6% in 2008. The proportion of levofloxacin resistant strains of Pseudomonas aeruginosa and Enterococcus faecalis decreased from previous reports and the proportion of multidrug-resistant P. aeruginosa and carbapenem-resistant Enterobacteriaceae remained low. Among methicillin-resistant Staphylococcus aureus (MRSA) strains, strains with reduced susceptibility to vancomycin (minimum inhibitory concentration, 2 µg/mL) increased to 14.7% from 5.5%. Bacterial strains that produced extended-spectrum ß-lactamase included E. coli (79 of 325 strains, 24.3%), Klebsiella pneumoniae (9 of 177 strains, 7.7%), and Proteus mirabilis (6 of 55 strains, 10.9%). The proportion of extended-spectrum ß-lactamase producing E. coli and K. pneumoniae strains increased from previous surveillance reports.


Asunto(s)
Bacterias/aislamiento & purificación , Infecciones Bacterianas/microbiología , Pruebas de Sensibilidad Microbiana/métodos , Infecciones Urinarias/epidemiología , Infecciones Urinarias/microbiología , Adulto , Anciano , Anciano de 80 o más Años , Antibacterianos/uso terapéutico , Bacterias/efectos de los fármacos , Infecciones Bacterianas/tratamiento farmacológico , Infecciones Bacterianas/epidemiología , Farmacorresistencia Bacteriana/efectos de los fármacos , Enterococcus faecalis/efectos de los fármacos , Escherichia coli/efectos de los fármacos , Femenino , Fluoroquinolonas/uso terapéutico , Humanos , Japón/epidemiología , Klebsiella pneumoniae/efectos de los fármacos , Levofloxacino/farmacología , Masculino , Staphylococcus aureus Resistente a Meticilina/efectos de los fármacos , Persona de Mediana Edad , Proteus mirabilis/efectos de los fármacos , Pseudomonas aeruginosa/efectos de los fármacos , Infecciones Urinarias/tratamiento farmacológico , Vancomicina/uso terapéutico , Adulto Joven
2.
Nihon Hinyokika Gakkai Zasshi ; 107(4): 266-270, 2016.
Artículo en Japonés | MEDLINE | ID: mdl-29070742

RESUMEN

Carcinosarcoma of the prostate is a rare but aggressive tumor characterized by combination of malignant epithelial and mesenchymal cells. We encountered a case of carcinosarcoma of the prostate. A 78-year-old man with urinary retention was diagnosed with benign prostatic hyperplasia on the basis of the ultrasonography and rectal examination findings, negative result of prostate biopsy. Transurethral resection of the prostate was performed, and the pathological diagnosis was carcinosarcoma of the prostate with squamous cell carcinoma. The patient died of disease 5 months after the diagnosis of carcinosarcoma. A total of 17 cases of carcinosarcoma of the prostate including the present case, have been reported in the Japanese literature to date. Herein we review the 17 cases and discuss the clinical features.

3.
J Infect Chemother ; 21(9): 623-33, 2015 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-26166322

RESUMEN

To investigate antimicrobial susceptibility patterns of various bacterial pathogens isolated from complicated urinary tract infection (UTI) cases, the Japanese Society of Chemotherapy, the Japanese Association of Infectious Disease, and the Japanese Society of Clinical Microbiology conducted the second nationwide surveillance from January to September 2011. With the cooperation of 42 medical institutions throughout Japan, 1036 strains belonging to 8 clinically relevant bacterial species were collected. Among methicillin-resistant Staphylococcus aureus (MRSA) strain, the vancomycin (VCM) MIC for 5.5% (3/55) of the strains was 2 µg/mL. Ampicillin, VCM, and linezolid were relatively active against 209 Enterococcus faecalis strains. The proportion of fluoroquinolone (FQ)-resistant strains was >20%. The MIC90 of FQs against the 382 Escherichia coli strains was 2-64 mg/L and the proportion resistant to FQs was approximately 30%. However, susceptibility of E. coli to sitafloxacin was still high (MIC90 = 2 mg/L). Fifty-eight (15.2%) of 382 E. coli, 6 (4.5%) of 132 Klebsiella pneumoniae, 1 (2.4%) of 41 Klebsiella oxytoca and 4 (6.8%) of 59 Proteus mirabilis strains were suspected of producing extended-spectrum beta-lactamase. Of 93 Pseudomonas aeruginosa strains, the proportions resistant to imipenem, amikacin, and ciprofloxacin were 21.5%, 4.3%, and 20.4%, respectively. Four strains (4.3%) were found to be multidrug-resistant. In complicated UTI cases, all of MRSA and E. faecalis were susceptible to all anti-MRSA agents. Sitafloxacin was active against other FQ-resistant E. coli strains. The isolation of extended-spectrum beta-lactamase-producing and multidrug-resistant strains increased.


Asunto(s)
Antibacterianos/farmacología , Enterococcus faecalis/efectos de los fármacos , Bacterias Gramnegativas/efectos de los fármacos , Staphylococcus aureus Resistente a Meticilina/efectos de los fármacos , Vigilancia de la Población , Infecciones Urinarias/microbiología , Anciano , Anciano de 80 o más Años , Amicacina/farmacología , Ampicilina/farmacología , Ciprofloxacina/farmacología , Farmacorresistencia Bacteriana Múltiple , Escherichia coli/efectos de los fármacos , Femenino , Fluoroquinolonas/farmacología , Humanos , Imipenem/farmacología , Japón , Klebsiella oxytoca/efectos de los fármacos , Klebsiella pneumoniae/efectos de los fármacos , Linezolid/farmacología , Masculino , Pruebas de Sensibilidad Microbiana , Persona de Mediana Edad , Proteus mirabilis/efectos de los fármacos , Pseudomonas aeruginosa/efectos de los fármacos , Serratia marcescens/efectos de los fármacos , Vancomicina/farmacología
4.
Antibiotics (Basel) ; 3(2): 109-20, 2014 Apr 02.
Artículo en Inglés | MEDLINE | ID: mdl-27025738

RESUMEN

To clarify the clinical efficacy of a single oral 2 g dose of azithromycin extended-release for heterosexual male patients with urethritis, and the current antimicrobial sensitivity of Neisseria gonorrhoeae to azithromycin, a prospective clinical trial was conducted from 2011-2013. In patients with gonococcal urethritis, the eradication rate was 90.9% (30 of 33). The susceptibility rates of isolated Neisseria gonorrhoeae strains to ceftriaxone, spectinomycin, cefixime and azithromycin were 100%, 100%, 95.3% (41/43) and 37.2% (16/43), respectively. In the patients with nongonococcal urethritis, the eradication rate was 90.0% (45 of 50). The microbiological eradication rates for the pathogens were 90.9% (30/33) for Neisseria gonorrhoeae, 91.5% (43/47) for Chlamydia trachomatis, 71.4% (5/7) for Mycoplasma genitalium, and 100% (13/13) for Ureaplasma urealyticum. The main adverse event was diarrhea and its manifestation rate was 35.2% (32 of 120). The symptom of diarrhea was mostly temporary and resolved spontaneously. The conclusion was that the treatment regimen with a single oral 2 g dose of azithromycin extended-release would be effective for patients with urethritis. However, the antimicrobial susceptibilities of Neisseria gonorrhoeae and Mycoplasma genitalium should be carefully monitored because of possible treatment failure.

5.
Int J Clin Oncol ; 7(3): 159-64, 2002 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-12109517

RESUMEN

BACKGROUND: We aimed to evaluate the pathological features of hypovascular or avascular renal cell carcinoma (RCC), by the retrospective review of the histological features that coincide with hypovascular or avascular RCC. METHODS: Seven hundred and ninety-one patients who underwent both preoperative angiography and nephrectomy were examined. Of these patients, the 126 patients (15.9%) who showed hypovascular or avascular angiographic features were selected. Patients with hemorrhage or cyst(s), or with at least 50% necrosis or more in the tumor, and those with renal tumor metastatic to the kidney were excluded. The criteria proposed by the World Health Organization (1998) were adopted for the histological classification. RESULTS: Papillary RCC was the most frequently observed hypovascular or avascular renal tumor (44 cases; 34.9%). The vascularity differed among the variants, i.e., some cases had a basophilic and solid variant with avascular features, while the remaining cases had wide stromal organization showing hypovascular features. The second most frequently observed hyporascular or avascular RCC was chromophobe cell carcinoma (35 cases; 27.8%). No difference in vascularity was detected between variants, except for 2 cases with sarcomatoid changes (avascular features). The third most frequently observed hypovascular or avascular RCC was cyst-associated RCC (29 cases; 23%). All of the 7 RCCs originating in a cyst showed avascular features, and the remaining 22 cystic RCCs showed hypovascular features. The remaining hypovascular or avascular RCCs were cases of clear cell carcinoma accompanied by sarcomatoid changes (8 cases; 6.3%), spindle cell carcinoma (5 cases; 4.0%), and collecting-duct carcinoma (5 cases; 4.0%). CONCLUSION: Hypovascular or avascular RCC can be categorized as non-clear cell carcinoma and some clear cell carcinoma accompanied by sarcomatoid changes.


Asunto(s)
Carcinoma de Células Renales/irrigación sanguínea , Carcinoma de Células Renales/patología , Neoplasias Renales/irrigación sanguínea , Neoplasias Renales/patología , Neovascularización Patológica/patología , Hospitales Universitarios , Humanos , Túbulos Renales Colectores/irrigación sanguínea , Túbulos Renales Colectores/patología , Nefrectomía , Pronóstico , Estudios Retrospectivos
6.
Int J Urol ; 10(11): 587-94, 2003 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-14633083

RESUMEN

BACKGROUND: The aim of the study presented here was to stratify drug therapy for patients with benign prostatic hyperplasia (BPH) displaying various voiding symptoms. METHODS: Two different alpha1-adrenoceptor antagonists; tamsulosin hydrochloride (Tam) and naftopidil (Naf ), were administered to 96 patients with BPH for 8 weeks in a crossover study. RESULTS: With the administration of both drugs, the International Prostate Symptom Score (I-PSS) significantly decreased and the maximum urinary flow significantly increased. Whereas Naf monotherapy decreased the I-PSS for storage symptoms, Tam monotherapy decreased the I-PSS for voiding symptoms. In both the Naf-to-Tam and Tam-to-Naf groups, crossover was effective when the initial drug was judged subjectively and objectively to have been ineffective. Compliance was acceptable with both drugs. CONCLUSION: Our results show that either Naf or Tam can be used to treat patients on the basis of objective and subjective assessment of voiding symptoms. Our findings should be helpful for patient guidance and treatment of BPH.


Asunto(s)
Antagonistas Adrenérgicos alfa/uso terapéutico , Naftalenos/uso terapéutico , Piperazinas/uso terapéutico , Hiperplasia Prostática/complicaciones , Hiperplasia Prostática/tratamiento farmacológico , Sulfonamidas/uso terapéutico , Trastornos Urinarios/tratamiento farmacológico , Trastornos Urinarios/etiología , Anciano , Estudios Cruzados , Mareo/inducido químicamente , Cefalea/inducido químicamente , Humanos , Hipotensión Ortostática/inducido químicamente , Masculino , Persona de Mediana Edad , Satisfacción del Paciente , Hiperplasia Prostática/clasificación , Calidad de Vida , Tamsulosina , Resultado del Tratamiento , Trastornos Urinarios/clasificación
7.
Antimicrob Agents Chemother ; 46(12): 3744-9, 2002 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-12435671

RESUMEN

Neisseria gonorrhoeae strains with reduced susceptibility to cefixime (MICs, 0.25 to 0.5 micro g/ml) were isolated from male urethritis patients in Tokyo, Japan, in 2000 and 2001. The resistance to cephems including cefixime and penicillin was transferred to a susceptible recipient, N. gonorrhoeae ATCC 19424, by transformation of the penicillin-binding protein 2 gene (penA) that had been amplified by PCR from a strain with reduced susceptibility to cefixime (MIC, 0.5 micro g/ml). The sequences of penA in the strains with reduced susceptibilities to cefixime were different from those of other susceptible isolates and did not correspond to the reported N. gonorrhoeae penA gene sequences. Some regions in the transpeptidase-encoding domain in this penA gene were similar to those in the penA genes of Neisseria perflava (N. sicca), Neisseria cinerea, Neisseria flavescens, and Neisseria meningitidis. These results showed that a mosaic-like structure in the penA gene conferred reductions in the levels of susceptibility of N. gonorrhoeae to cephems and penicillin in a manner similar to that found for N. meningitidis and Streptococcus pneumoniae.


Asunto(s)
Proteínas Bacterianas , Proteínas Portadoras , Cefixima/farmacología , Hexosiltransferasas/genética , Complejos Multienzimáticos/genética , Muramoilpentapéptido Carboxipeptidasa , Neisseria gonorrhoeae/genética , Peptidil Transferasas/genética , Secuencia de Aminoácidos , Hexosiltransferasas/efectos de los fármacos , Humanos , Masculino , Pruebas de Sensibilidad Microbiana , Datos de Secuencia Molecular , Mosaicismo/genética , Complejos Multienzimáticos/efectos de los fármacos , Neisseria gonorrhoeae/efectos de los fármacos , Neisseria gonorrhoeae/aislamiento & purificación , Proteínas de Unión a las Penicilinas , Peptidil Transferasas/efectos de los fármacos
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA